title: [Medical treatment of neuropathic pain].
abstract: Neuropathic pain represents a diagnostic challenge and is difficult to treat. In recent years, clinical trials have led to the development of a number of new treatment guidelines. The guidelines recommend drugs for the most important types of neuropathic pain and suggest alternatives in the event of lack of effect or intolerable adverse effects. Patients with this condition often suffer from anxiety, depression and insomnia, which influences the choice of drug. This article presents the most important drugs on which these guidelines concur.
authors: Oslo Nevroklinikk, Norway.
authors: Geir D
authors: GD
authors: Slapø
authors: Jan
authors: J
authors: Schjøtt
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D000700:Analgesics / Q000493:pharmacokinetics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000493:pharmacokinetics / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000493:pharmacokinetics / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy* / Q000503:physiopathology; D017933:Peripheral Nervous System / Q000187:drug effects / Q000502:physiology; D017410:Practice Guidelines as Topic
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000700:Analgesics; D000701:Analgesics, Opioid; D000929:Antidepressive Agents, Tricyclic